Double Medical Technology Inc. (SHE:002901)
54.39
+0.94 (1.76%)
Sep 5, 2025, 3:04 PM CST
Double Medical Technology Revenue
Double Medical Technology had revenue of 660.10M CNY in the quarter ending June 30, 2025, with 22.96% growth. This brings the company's revenue in the last twelve months to 2.38B, up 36.29% year-over-year. In the year 2024, Double Medical Technology had annual revenue of 2.14B with 39.29% growth.
Revenue (ttm)
2.38B
Revenue Growth
+36.29%
P/S Ratio
9.28
Revenue / Employee
528.95K
Employees
4,503
Market Cap
22.12B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.14B | 602.44M | 39.29% |
Dec 31, 2023 | 1.53B | 99.02M | 6.90% |
Dec 31, 2022 | 1.43B | -560.23M | -28.09% |
Jan 1, 2022 | 1.99B | 407.47M | 25.68% |
Dec 31, 2020 | 1.59B | 329.54M | 26.21% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 30.15B |
WuXi AppTec | 41.90B |
Shenzhen Mindray Bio-Medical Electronics | 32.94B |
Sichuan Biokin Pharmaceutical | 441.19M |
Zhangzhou Pientzehuang Pharmaceutical., | 10.52B |
Aier Eye Hospital Group | 21.94B |
Shanghai United Imaging Healthcare | 10.98B |
Yunnan Baiyao Group Co.,Ltd | 40.84B |